Oscar Gallego Rubio
0000-0001-5665-0967
Hospital de la Santa Creu i Sant Pau
2 papers found
Refreshing results…
RNA-Sequencing and immunohistochemistry reveal ZFN7 as a stronger marker of survival than molecular subtypes in G-CIMP-negative glioblastoma
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
Missing publications? Search for publications with a matching author name.